Fundraising Fox

Cytonics

Jupiter, US · Founded 2006 · Florida corporation · 13 employees on LinkedIn

Find your way into Cytonics

112 people in our graph share verified history with the Cytonics team — schools, employers, funds. One of them is your warm intro.

Demi Obayomiunlockedknows Joey Bose · together at The Johns Hopkins University (overlapped)
×9knows the team · via The Johns Hopkins University
×2knows the team · via University of Virginia

Cytonics develops biologic therapies targeting osteoarthritis, with lead candidate CYT-108, a recombinant protease inhibitor for knee joint regeneration based on a novel pathway to restore cartilage-secreting cells. The company funds development through equity crowdfunding from individual investors rather than venture capital.

BiotechHealthtechLongevityMedical Devices

Founders & leadership

JBJoey Bose
Joey BoseinChief Executive OfficerVenture Partner at Intelligence Ventures

Reported raises · per SEC filings

Form D private placements

$839K disclosed across 3 rounds · 2018–2019

▶$20KraisedJun 2019 · 1 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Joey BoseExecutive Officer
Offering amount
$450K
Amount sold
$20K
Minimum investment
$20K
Sales commissions
$1.5K
Placement agents
SI Securities, LLC
First sale
Jun 2019
Incorporated
Corporation, Florida
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$25KraisedJun 2019 · 1 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Joey BoseExecutive Officer
Offering amount
$450K
Amount sold
$25K
Minimum investment
$20K
Sales commissions
$1.9K
Placement agents
SI Securities, LLC
First sale
Apr 2019
Incorporated
Corporation, Florida
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$794KraisedDec 2018 · 20 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Joey BoseExecutive Officer
Offering amount
$1M
Amount sold
$794K
Minimum investment
$25K
First sale
Jun 2018
Incorporated
Corporation, Florida
Federal exemptions
06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 4

by search overlap
Cytokinetics30 shared keywordsCytokinetics develops potential medicines for cardiovascular and neuromuscular diseases characterized by impaired muscle function. The company specializes in sarcomere-directed therapies targeting conditions involving muscle weakness, loss, and dysfunction.
Tectonic Therapeutic17 shared keywordsTectonic is a clinical-stage biotechnology company developing therapeutic proteins and antibodies that target G-Protein Coupled Receptors (GPCRs) using a proprietary platform called GEODe™. The company focuses on therapeutic areas with significant unmet medical needs where current treatment options are limited or absent.
CytomX15 shared keywordsCytomX is a clinical-stage biopharmaceutical company developing conditionally activated biologic cancer therapies, including antibody-based treatments designed to target tumors while limiting effects on healthy tissue. It advances a pipeline of Probody therapeutics through preclinical research and clinical trials in oncology.
Cytonus Therapeutics15 shared keywords

Companies competing with Cytonics for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2011$1.6M
National Institutes of Health (NIH)National Institutes of HealthPhase I2010$192.3K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

No Drug Has Ever Cured This $560B Disease. This Biotech Believes They've Made One.barchart.com · Jul 2026No VCs allowed: This biotech startup is funded solely by retail investorsmorningbrew.com · Jun 2026Cytonics on StartEngine 2025 - Kingscrowdkingscrowd.com · Mar 2025#57: 👎 Why Cytonics Turned Down VCcytonics.comInvestors – Cytonics Corporationcytonics.comCytonics Announces Launch of Regulation A+ Equity Crowdfunding Campaign to Fund Phase 2 Development – Cytonics Corporationcytonics.com

Frequently asked questions

What does Cytonics do?
Cytonics develops biologic therapies targeting osteoarthritis, with lead candidate CYT-108, a recombinant protease inhibitor for knee joint regeneration based on a novel pathway to restore cartilage-secreting cells. The company funds development through equity crowdfunding from individual investors rather than venture capital.
How much funding has Cytonics raised?
Cytonics has disclosed $839K raised across 3 rounds.
Where is Cytonics headquartered?
Cytonics is headquartered in Jupiter, US.